1. Home
  2. People
  3. Research Faculty

Research Faculty

banner
Celine Sze Ling CHUI
Celine Sze Ling CHUI

BS, MSc, PhD

Assistant Professor

[javascript protected email address]
3917 6629

ORCID

Professor Celine Chui is currently an Assistant Professor at the School of Nursing, The University of Hong Kong. She earned her Bachelor's degree from the University of California, Los Angeles (UCLA), and is a Fellow with Distinction (FFPH) from the Faculty of Public Health of the Royal Colleges of Physicians of the United Kingdom as well as a Fellow of the Higher Education Academy (FHEA) through Advance HE, United Kingdom. She has received numerous awards and recognitions, including being listed among the world’s top 2% most cited scientists by Stanford University since 2023, the HKU Li Ka Shing Faculty of Medicine Outstanding Research Output Award, the Knowledge Exchange (KE) Award, the John Snow Award, and the Emerging Leader Award from the International Society on Pharmacoepidemiology.

Prof.  Chui has an H-index of 37 and has authored over 170 articles in peer-reviewed journals such as The Lancet Infectious Diseases, BMJ, JAMA Internal Medicine, npj Digital Medicine, and Neurology. Her research interest is utilizing real-world evidence to enhance population health outcomes through knowledge translation and dissemination science. She is the principal investigator or research lead of several funded competitive grants including Collaborative Research Fund, Health and Medical Research Fund Fellowship / Commission, Early Career Scheme, General Research Fund and Innovation and Technology Commission Partnership Research Programme. Professor Chui is also one of the lead researchers in the COVID-19 Vaccines Adverse Events Response and Evaluation (CARE) Programme, a comprehensive surveillance programme to monitor known and potential adverse events of COVID-19 vaccines. She is the current chair and convener of NeuroGEN (Neurological and Mental Health Global Epidemiology Network).

Prof. Chui  developed an AI-powered risk prediction tool for assessing the risk of cardiovascular events among the Chinese population, named Personalised Cardiovascular Disease Risk Assessment for Chinese (P-CARDIAC). It demonstrated outstanding performance following validation with comprehensive data from Hong Kong. She is now leading an on-going implementation study of P-CARDIAC which will have a significant impact on improvements in patient outcomes and a reduction in healthcare burden.  

More

Co-principal investigator or research lead*

Funding Scheme Project Title Approved Amount (HK$)
Research Grant Council (RGC) General Research Fund External validation of machine-learning driven risk prediction model for 10-year risk of cardiovascular diseases: a multi-database study 872,085
Research Grant Council (RGC) Collaborative Research Fund (CRF) Attention-deficit hyperactive disorder Care in Children: Organized Research Data (ACCORD) Platform 8,168,164
Health and Medical Research Fund (HMRF) Fellowship Scheme Risk factors for extended carbapenem-resistant Enterobacteriaceae colonization: a big data analytic study 1,172,976
Research Grant Council (RGC) Early Career Scheme Safe Antibiotics use in the Management of PEople with Dementia (SAMPED) 921,882
Food and Health Bureau, The Government of the Hong Kong Special Administrative Region COVID-19 vaccines Adverse events Response and Evaluation (CARE) Programme* 10,000,000
RGC Collaborative Research Fund (CRF) Coronavirus Disease (COVID-19) and Novel Infectious Disease (NID) Research Exercise* A multinational big data Covid-19 Epidemiological Study on post-infection Outcomes (ACESO) 9,691,060
Innovation and Technology Fund, Partnership Research Programme Cardiovascular risk prediction model for patients on lipid modifying drugs 3,047,842
Research Grant Council (RGC) General Research Fund Association between the use of different classes of blood pressure-lowering drugs and risk of incident dementia: a multidatabase study 694,305
Health and Medical Research Fund (HMRF) Commissioned Paediatric Research at Hong Kong Children’s Hospital* Epidemiology and effect of antibiotic exposure on antimicrobial resistance bacterial carriages and gut microbiota among children and their caregivers in the Hong Kong Children’s Hospital* 1,544,933
  1. Chen K, Lau JCH, Qin X, Lee EMH, Hui WWS, Kwok JYY, Luo H, Lau GKK, Yuen JKY, Yu DSF, Wong ICK, Chui CSL*. Association between repeated antibiotic prescribing and seizure- and other neuropsychiatric disorders-related hospitalization among people living with dementia: a population-based cohort study. npj Aging 2026 Feb 17;12(1):44. Available from: doi: 10.1038/s41514-025-00316-y
  2. Cheung ECL, Wang Y, Kalisch-Ellett L, Adesuyan M, Szilcz M, Shah S, Pratt N, Brauer R, Jani YH, Smith RD, Luo H, Yuen JK, Hägg S, Chui CSL*. Prescribing trends and time series analysis of blood pressure-lowering drugs among patients with dementia: a multinational database study. EClinicalMedicine. 2025 Oct 30;90:103595. Available from: doi: 10.1016/j.eclinm.2025.103595
  3. Zhou Y, Luo R, Blais JE, Tan KCB, Lui DTW, Yiu KH, Lai FTT, Wan EYF, Cheung CL, Wong IC, Chui CS*. Optimizing long term disease prevention with reinforcement learning: a framework for precision lipid control. npj Digital Medicine. 2025 Aug 27;8(1):553. Available from: doi: 10.1038/s41746-025-01951-1
  4. Cheung ECL, Adesuyan M, Szilcz M, Kalisch Ellett LM, Shah S, Jani YH, Hägg S, Pratt N, Lau KK, Luo H, Wan EYF, Chan EWY, Wong ICK, Yuen JK, Yiu KH, Howard R, Brauer R, Chui CSL*. Antihypertensive drug classes and risk of incident dementia: a multinational population-based cohort study. Age and Ageing. 2025 May 3;54(5):afaf121. Available from: doi: 10.1093/ageing/afaf121
  5. Zhou Y, Lin CJ, Yu Q, Blais JE, Wan EYF, Lee M, Wong E, Siu DC, Wong V, Chan EWY, Lam TW, Chui W, Wong ICK, Luo R, Chui CSL*. Development and validation of risk prediction model for recurrent cardiovascular events among Chinese: the Personalized CARdiovascular DIsease risk Assessment for Chinese model. European Heart Journal - Digital Health. 2024 Apr 8;5(3):363-370. Available from: doi: 10.1093/ehjdh/ztae018
  6. Fan M, Lai FTT, Cheng FWT, Tsie NTY, Li X, Wan EYF, Wong CKH, Chan EWY, Yiu KH, Wong ICK*, Chui CSL*. Risk of carditis after three doses of vaccination with mRNA (BNT162b2) or inactivated (CoronaVac) covid-19 vaccination: a self-controlled cases series and a case-control study. The Lancet Regional Health. Western Pacific. 2023 Jun;35:100745. Available from: doi: 10.1016/j.lanwpc.2023.100745
  7. Fan M, Wong SC, Yu Q, Li PH, Wu P, Chan EWY, Wong ICK, Tun HM, Cowling BJ, Cheng VC, Chui CSL*. Epidemiology and risk factors for Carbapenemase-Producing Enterobacteriaceae carriage in the hospital: a population-based nested case-control study. Journal of Global Antimicrobial Resistance. 2023 Jun;33:242-248. Available from: doi: 10.1016/j.jgar.2023.03.013
  8. Chui CSL#, Wan EYF#, Ng VWS, Wang Y, Yan VKC, Lam ICH, Fan M, Lai FTT, Chan EWY, Li X, Wong CKH, Chung RKC, Cowling BJ, Fong WC, Lau AYL, Mok VCT, Chan FLF, Lee CK, Chan LST, Lo D, Lau KK, Hung IFN, Lau CS, Leung GM, Wong ICK. Messenger RNA Coronavirus Disease 2019 (COVID-19) vaccination With BNT162b2 increased risk of Bell's palsy: a nested case-control and self-controlled case series study. Clinical Infectious Diseases. 2023 Feb 8;76(3):e291-e298. Available from: doi: 10.1093/cid/ciac460
  9. Chui CSL#, Fan M#, Wan EYF, Leung MTY, Cheung E, Yan VKC, Gao L, Ghebremichael-Weldeselassie Y, Man KKC, Lau KK, Lam ICH, Lai FTT, Li X, Wong CKH, Chan EW, Cheung CL, Sing CW, Lee CK, Hung IFN, Lau CS, Chan JYS, Lee MKY, Mok VCT, Siu CW, Chan LST, Cheung T, Chan FLF, Leung AYH, Cowling BJ, Leung GM, Wong ICK. Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: a self-controlled case series study. EClinicalMedicine. 2022 Jun 25;50:101504. Available from: doi: 10.1016/j.eclinm.2022.101504
  10. Chui CSL#, Wan EYF#, Lai FTT, Chan EWY, Li X, Yan VKC, Gao L, Yu Q., Lam ICH, Chun RKC, Cowling BJ, Fong WC, Lau AYL, Mok VCT, Chan FLF, Lee CK, Chan LST, Lo D, Lau KK, Hung IFN, Leung GM, Wong ICK. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study. The Lancet Infectious Diseases. 2022 Jan;22(1):64-72. Available from: doi: 10.1016/S1473-3099(21)00451-5
Since 2025 Editorial Board Member, Scientific Reports
Since 2024 Associate Editor, Pharmacoepidemiology and Drug Safety Since 2022     Editorial Board Member, Scientific Reports

The Lancet, JAMA Network Open, Psychological Medicine, British Journal of Clinical Pharmacology, PLoS One, Journal of Antimicrobial Chemotherapy, Hong Kong Journal of Paediatrics, BMC Musculoskeletal Disorder, Scientific Reports

2026/07-current Long-term Guest Reviewer of Peadiatric Nursing Clinical Project Group, Hong Kong West Cluster, Hospital Authority, Hong Kong
2024/06-2026/06 Academic Visitor, Infection and Immunity Research Institute, City St George’s, University of London, London, United Kingdom
Since 2022 Steering Committee Member, The Observational Health Data Sciences and Informatics (OHDSI) Asia-Pacific Community (APAC)
2021/03- 2024/03 Honorary Advisor in Quality and Safety Division of Hospital Authority Head Office (HAHO), Hong Kong Government
2020/11-2025/10 Co-principal investigator, Data Discovery for Health (D24H), AIR@InnoHK, Science Park, Hong Kong
2019/11-current Honorary Research Fellow, UCL School of Pharmacy, London, United Kingdom
2019/02-current Honorary Research Assistant, Department of Pharmacy, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China
2018/01-current Member, The University of Hong Kong Shenzhen Institute of Research and Innovation, Shenzhen, China
2018-current Convener and active member NeuroGEN (Neurological and Mental Health Global Epidemiology Network)
2015-16 Chair, Student Council, International Society for Pharmacoepidemiology
2014-15 Co-chair, Student Council, International Society for Pharmacoepidemiology
2014 Visiting Scholar, London School of Hygiene and Tropical Medicine, London, United Kingdom
  • Emerging Leader Award in the 41st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management 2025
  • World’s top 2% most cited scientists by Stanford University 2023-25
  • Knowledge Exchange (KE) Award, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 2023
  • Outstanding Research Output Award, Li Ka Shing Faculty of Medicine, The University of Hong Kong, 2017, 2022-24
  • ASM Student and Postdoctoral Travel Award, ASM (American Society for Microbiology) Microbe, 2018
  • John Snow Award (Best abstract submitted from a female research or a student living in a developing country), 32nd ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 2016
  • Roche Postgraduate Research Student Prize, The University of Hong Kong, 2015
  • Rising Start Award, 9th Asian Conference on Pharmacoepidemiology, 2015
  • First Poster Prize, 14th Annual Meeting of the International Society of Pharmacovigilance, 2014
  • Best Presenter Award in Cardiovascular Issues and Antibiotics, 8th Asian Conference on Pharmacoepidemiology, 2013
Back